| Otolaryngology |
1 |
1 |
| Anaphylaxis |
0 |
0.9 |
| Food and Drug Administration (FDA) |
0 |
0.5 |
| Polyp |
0 |
0.42 |
| Surgery |
0 |
0.42 |
| Nasal Polyp |
0 |
0.41 |
| Revenue and Practice Management |
0 |
0.33 |
| Child |
0 |
0.28 |
| Insurance |
0 |
0.28 |
| Pollex |
0 |
0.28 |
| Allergic Rhinitis |
0 |
0.24 |
| Biologic Therapy |
0 |
0.19 |
| Food Allergy |
0 |
0.16 |
| Allergy |
0 |
0.14 |
| Beta-Adrenergic Agonist |
0 |
0.14 |
| Blood |
0 |
0.14 |
| Board Certification |
0 |
0.14 |
| Clinical Guidelines |
0 |
0.14 |
| Epidemic |
0 |
0.14 |
| Femoral |
0 |
0.14 |
| Health Education and Counseling |
0 |
0.14 |
| Nasal Mucosa |
0 |
0.14 |
| New York |
0 |
0.14 |
| Nose |
0 |
0.14 |
| Pharmacokinetics |
0 |
0.14 |
| Phobia |
0 |
0.14 |
| Private Practice |
0 |
0.14 |
| Rhinitis |
0 |
0.14 |
| Steroids |
0 |
0.14 |
| Stress |
0 |
0.14 |
| Anxiety Disorder |
0 |
0.11 |